This leads to an increase in the function of the PD-1/PD-L1 system in the TIME, with down-modulation of the TCR signalosome in tumor-infiltrating CD8+ T cells, leading to impairment of the immune response to the tumor [48,49]. Here, CD274 is linked to neoplasm.